NewsMedTrace Accelerates Phase III Trial and Announces Appointment of Nicholas Borys as Chief Medical OfficerMedTrace Accelerates Phase III Trial and Announces Appointment of Nicholas Borys as Chief Medical Officer Today, pharma and medical imaging company MedTrace announced the appointment...
NewsExperience MedTrace’s Evaluation Software, aQuant, at ASNC2024 in AustinExperience MedTrace’s Evaluation Software, aQuant, at ASNC2024 in Austin, Texas We’re excited to showcase our patented analysis software, aQuant, at the 29th Annual Scientific Session...
NewsExperience MedTrace’s 15O-Water Technologies at the SNMMI 2024 Annual MeetingExperience MedTrace’s 15O-Water Technologies at the SNMMI 2024 Annual Meeting MedTrace is proud to participate with a booth and demonstrate its 15O-water technologies at this...
NewsWhat Is 15O-Water, and Why Is MedTrace So Eager to Make It Available in Clinical Practice? What Is 15O-Water, and Why Is MedTrace So Eager to Make It Available in Clinical Practice? 1 Xie et al Med Phys. 2015 Jun; 42(6):...
NewsFirst CE Mark for Patient Kits as Medical Devices Obtained by MedTrace First CE Mark for Patient Kits as Medical Devices Obtained by MedTrace CEO Ann Kristin Led and CTO Lars Trolle in front of MedTrace’s automated...
NewsShrinking the Manufacturing Footprint with PET Point-of-CareShrinking the Manufacturing Footprint with PET Point-of-Care Jared Driskill, Sr. Medical Advisor at MedTrace “Today, most PET radiopharmaceuticals are produced at centralized locations and distributed....
NewsThe First Scientific Article Based on a MedTrace-Sponsored Study Has Been PublishedThe First Scientific Article Based on a MedTrace-Sponsored Study Has Been Published MedTrace is proud to see the methodology paper “Rationale and design of the...
NewsMedTrace Has Activated Four New U.S. Sites, Adding Momentum and Excitement Around Its Phase III Clinical TrialMedTrace Has Activated Four New U.S. Sites, Adding Momentum and Excitement Around Its Phase III Clinical Trial Installation of MedTrace’s point-of-care manufacturing system, P3 MT-100....
NewsMedTrace Appoints New Executive Management Team: Current CFO Ann Kristin Led Is the New CEO/CFO of MedTraceMedTrace Appoints New Executive Management Team: Current CFO Ann Kristin Led Is the New CEO/CFO of MedTrace Ann Kristin Led Pharmaceutical and medical device company...
NewsNew Research Concludes that 15O-Water PET Can Be Used to Assess Blood Flow of the Right VentricleNew Research Concludes that 15O-Water PET Can Be Used to Assess Blood Flow of the Right Ventricle At MedTrace we keep a close eye on...
NewsMedTrace Is Proud to Sponsor the Women in Nuclear Cardiology Event at ASNC2023MedTrace is proud to sponsor The Women in Nuclear Cardiology Event at ASNC2023 MedTrace is showcasing its technology and Phase 3 Clinical Trial at ASNC2023,...
NewsMedTrace Receives an 18 Million Euro Investment for Completion of Its Phase 3 TrialMedTrace Receives an 18 Million Euro Investment for Completion of its Phase 3 Trial The Danish pharmaceutical and medical device company MedTrace has just closed...
News15O-Water Demonstrations at EANM’23: Experience the Daily Preparation and Setup of MedTrace’s 15O-Water Automated Manufacturing System15O-Water Demonstrations at EANM’23: Experience the Daily Preparation and Setup of MedTrace’s 15O-Water Automated Manufacturing System 15O-Water Demonstrations at EANM’23: Experience the Daily Preparation and...
ClinicalNewsMedTrace Hosts 15O-Water Symposium for Nuclear Medicine ProfessionalsMedTrace hosts 15O-water symposium for nuclear medicine professionals 15O-water: Ready for the Future. Vol. 2. The symposium, sponsored by MedTrace, will take place on September...
NewsMedTrace Expands Patent Portfolio and Protects Its 15O-Water TechnologyMedTrace Expands Patent Portfolio and Protects Its 15O-Water Technology The new patent protects how the company’s automated manufacturing system, P3 MT-100, produces and doses the...
NewsMedTrace Pharma’s Novel 15O-Water Technology Showcased at the SNMMI 2023 Annual MeetingMedTrace Pharma’s Novel 15O-Water Technology Showcased at the SNMMI 2023 Annual Meeting MedTrace Pharma is proud to participate with a clinical booth and share the...
ClinicalNewsMedTrace Earns ISO 13485 Certification, Meeting Stringent Standards for Medical DevicesMedTrace Earns ISO 13485 Certification, Meeting Stringent Standards for Medical Devices MedTrace is now ISO 13485 certified for the company’s quality management system in medical...
ClinicalNewsFirst U.S. Patient Scanned in MedTrace’s 15O-water Phase 3 TrialFirst U.S. Patient Scanned in MedTrace’s 15O-Water Phase 3 Trial The first U.S. patient in MedTrace’s phase 3 clinical trial has been dosed and scanned...
ClinicalNewsNew Findings from Aarhus University Hospital Shed Light on How 15O-Water PET MPI May Benefit Patients with Bypass SurgeryNew findings from Aarhus University Hospital shed light on how 15O-water PET MPI may benefit patients with bypass surgery 15O-water PET MPI may be a...
ClinicalNewsAarhus University Hospital Documents Frequent Extracardiac Findings on 15O-Water PET Myocardial Perfusion ImagingAarhus University Hospital document frequent extracardiac findings on 15O-water PET myocardial perfusion imaging From tumors and lung cancer to rib fractures and COVID-19 infiltrates. Researchers...
